0001209191-23-004068.txt : 20230119
0001209191-23-004068.hdr.sgml : 20230119
20230119174946
ACCESSION NUMBER: 0001209191-23-004068
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230102
FILED AS OF DATE: 20230119
DATE AS OF CHANGE: 20230119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: von Moltke Lisa
CENTRAL INDEX KEY: 0001808592
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36279
FILM NUMBER: 23538398
MAIL ADDRESS:
STREET 1: C/O SERESTHERAPEUTICS, INC.
STREET 2: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001346830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4 STAMFORD PLAZA
STREET 2: 107 ELM STREET 9TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-406-3700
MAIL ADDRESS:
STREET 1: 4 STAMFORD PLAZA
STREET 2: 107 ELM STREET 9TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
FORMER COMPANY:
FORMER CONFORMED NAME: Cara Therapeutics Inc
DATE OF NAME CHANGE: 20051213
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-02
0
0001346830
Cara Therapeutics, Inc.
CARA
0001808592
von Moltke Lisa
C/O CARA THERAPEUTICS, INC.
107 ELM STREET, 4 STAMFORD PLAZA
STAMFORD
CT
06902
1
0
0
0
Stock Option (Right to Buy)
10.74
2023-01-02
4
A
0
45841
0.00
A
2033-01-02
Common Stock
45841
45841
D
The shares shall vest and become exercisable in twelve (12) equal quarterly installments beginning on November 1, 2022, in each case subject to the Reporting Person's continued service as of each such date.
/s/ Darren DeStefano, Attorney-in-Fact
2023-01-19